Ftse Mib
33.067,99
-0,30%
DAX
19.261,75
-0,22%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
96.305,78
4,69%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Eledon Pharmaceuticals Inc (ELDN) Eledon Pharmaceuticals Inc (ELDN) Notizie

Eledon Pharmaceuticals Inc

ELDN
4,26
0,01 (0,24%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:30:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:51EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05EDGAR2Form 8-K - Current report
12/11/202422:01GLOBEEledon Pharmaceuticals Announces Recent Business Highlights..
06/11/202422:05GLOBEEledon Pharmaceuticals to Participate in Guggenheim..
05/11/202417:44EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
30/10/202411:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/10/202411:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/10/202402:27EDGAR2Form 8-K - Current report
29/10/202413:00EDGAR2Form 8-K - Current report
29/10/202412:46GLOBEEledon Pharmaceuticals Announces Pricing of $85 Million..
29/10/202412:45GLOBEEledon Pharmaceuticals Announces Positive Initial Data from..
03/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
01/10/202422:30EDGAR2Form 8-K - Current report
20/9/202423:00EDGAR2Form 8-K - Current report
20/9/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
11/9/202422:05GLOBEEledon Pharmaceuticals to Present at the Cantor Global..
04/9/202413:00GLOBEEledon Announces Completion of Enrollment in Phase 2 BESTOW..
19/8/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/8/202422:33EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
19/8/202422:30EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
14/8/202423:21GLOBEEledon Pharmaceuticals Reports Preliminary Second Quarter..
14/8/202423:15EDGAR2Form 8-K - Current report
14/8/202423:12EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
29/7/202413:00GLOBEEledon Provides Enrollment Update for Phase 2 BESTOW Trial..
12/7/202422:30EDGAR2Form 8-K - Current report
10/7/202422:47EDGAR2Form 8-K - Current report
10/7/202422:41EDGAR2Form 8-K - Current report
02/7/202422:05GLOBEEledon to Participate in the Leerink Partners Therapeutics..
14/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/6/202422:01GLOBEEledon Presents Updated Data from Ongoing Phase 1b Trial..
30/5/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
24/5/202422:02EDGAR2Form S-3 - Registration statement under Securities Act of..
15/5/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:30EDGAR2Form 8-K - Current report
09/5/202413:30GLOBEEledon Pharmaceuticals Reports First Quarter 2024 Operating..
09/5/202413:00GLOBEEledon Pharmaceuticals to Present Updated Data from Ongoing..
07/5/202413:15EDGAR2Form 8-K - Current report
07/5/202413:05GLOBEEledon Announces Clinical Progress with Tegoprubart in the..
07/5/202413:00GLOBEEledon Pharmaceuticals Announces Oversubscribed $50 Million..
28/3/202421:01GLOBEEledon Pharmaceuticals Reports Fourth Quarter and Full Year..
25/3/202421:56GLOBEEledon Pharmaceuticals Announces 12th Participant Enrolled..
21/3/202415:31GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart in..
14/2/202421:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 4,30 Min: 4,16 Max: 4,37
Chiusura: 4,25

La tua Cronologia

NASDAQ
ELDN
Eledon Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network